Nodding Disease
- All
- News
-
Cadila Seeks Nod To Repurpose Hepatitis C Drug For COVID-19 In India
A single dose of the Hepatitis C drug when taken early could help COVID-19 patients recover faster and avoid complications seen in the advanced stages of the disease, Cadila said.
-
Coronavirus India Live Updates: Serum Institute Gets Nod To Resume Oxford COVID-19 Vaccine Trial In India
India's COVID-19 case tally has crossed the 50-lakh mark with a spike of 90,123 new cases and 1,290 deaths - the highest the country has seen in 24 hours, the Union Health Ministry said. The total number of people who have died because of the disease now stands at 80,776.
-
Biocon Gets Regulatory Nod To Use Drug Itolizumab On COVID-19 Patients
The drug, which is also used to cure the skin disease psoriasis, was cleared by the Drug Controller General of India (DCGI) for usage in the country.
-
Hyderabad-Based Hetero Gets Regulatory Nod To Make Gilead's COVID-19 Drug
Hetero said its generic version of US-based Gilead Science's Remdesivir will be marketed under brand name Covifor in India.
-
Nawaz Sharif Flown To London In "High-End" Air Ambulance After Court Nod
Pakistan's former prime minister Nawaz Sharif today left for London in an air ambulance for medical treatment for multiple diseases after the Lahore High Court allowed him to travel abroad for four weeks and rejected the Imran Khan government's condition of furnishing an indemnity bond.
-
Woman, Mother Suffering Rare Genetic Disease Seek President's Nod For Passive Euthanasia
A woman and her 33-year-old daughter, suffering from muscular dystrophy, have written to President Ram Nath Kovind seeking permission for passive euthanasia.
-
Biocon, Quark Get DCGI's Nod For Trials Of Eye Disease Drug
Biopharmaceutical firm Biocon on Thursday said the Drug Controller General of India (DCGI) has given nod to it and partner Quark Pharmaceuticals to proceed with clinical trials on human subjects for a new drug candidate, 'QPI-1007' aimed for ocular neuroprotection.
-
Aurobindo Pharma Gets US Regulator's Nod for Gastro Reflux Drug
Drug firm Aurobindo Pharma has received final approval from US Food and Drug Administration (FDA) to manufacture and market Esomeprazole Magnesium delayed release capsules, used in treatment of gastro-esophageal reflux disease, in the American market.
-
Lupin Launches Generic Aricept Tablets in US Market
Drug major Lupin has launched Donepezil Hydrochloride tablets, used in treating Alzheimer's disease, in the US market after having received the US health regulator USFDA's nod for the product earlier.
-
Aurobindo Pharma Gets Final US FDA Nod For Dementia Drug
Drug firm Aurobindo Pharma has received final approval from US FDA to manufacture and market Rivastigmine Tartrate Capsules USP, used for the treatment of dementia disease, in the American market.
-
Aurobindo Gets US Regulator's Nod to Market Heart Disease Drug
Aurobindo Pharma has received approval of the US Food and Drug Administration (FDA) to market injection Eptifibatide, used in the treatment of acute coronary syndrome, in the American market.
-
Aurobindo Gets US Regulator's Nod for Multi Disease Treatment Injection
Drug firm Aurobindo Pharma on Wednesday said it has received final approval of the US health regulator to manufacture and market its dexamethasone sodium phosphate injection, used to treat various conditions such as severe allergic reactions, arthritis and blood diseases.
-
Jubilant Life Gets US Regulator's Nod for Generic Dementia Tablets
Drug firm Jubilant Life Sciences has received final approval from the US Food and Drug Administration (FDA) for generic Memantine Hydrochloride tablets, used for treatment of dementia in patients with Alzheimer's disease.
-
Aurobindo Pharma Gets FDA Nod for 2 Generic Drugs
Aurobindo Pharma on Monday announced receipt of final approval from the US health regulator to manufacture and market its generic versions of Parkinson's disease treatment drug Entacapone tablets and antibiotics Azithromycin in the American market.
-
Strides Arcolab Gets USFDA Nod for Generic Skin Disease Cream
The Bangalore-based company has received approval from the US Food and Drug Administration (USFDA) for Imiquimod cream, Strides Arcolab Ltd said in a statement.
-
Cadila Seeks Nod To Repurpose Hepatitis C Drug For COVID-19 In India
A single dose of the Hepatitis C drug when taken early could help COVID-19 patients recover faster and avoid complications seen in the advanced stages of the disease, Cadila said.
-
Coronavirus India Live Updates: Serum Institute Gets Nod To Resume Oxford COVID-19 Vaccine Trial In India
India's COVID-19 case tally has crossed the 50-lakh mark with a spike of 90,123 new cases and 1,290 deaths - the highest the country has seen in 24 hours, the Union Health Ministry said. The total number of people who have died because of the disease now stands at 80,776.
-
Biocon Gets Regulatory Nod To Use Drug Itolizumab On COVID-19 Patients
The drug, which is also used to cure the skin disease psoriasis, was cleared by the Drug Controller General of India (DCGI) for usage in the country.
-
Hyderabad-Based Hetero Gets Regulatory Nod To Make Gilead's COVID-19 Drug
Hetero said its generic version of US-based Gilead Science's Remdesivir will be marketed under brand name Covifor in India.
-
Nawaz Sharif Flown To London In "High-End" Air Ambulance After Court Nod
Pakistan's former prime minister Nawaz Sharif today left for London in an air ambulance for medical treatment for multiple diseases after the Lahore High Court allowed him to travel abroad for four weeks and rejected the Imran Khan government's condition of furnishing an indemnity bond.
-
Woman, Mother Suffering Rare Genetic Disease Seek President's Nod For Passive Euthanasia
A woman and her 33-year-old daughter, suffering from muscular dystrophy, have written to President Ram Nath Kovind seeking permission for passive euthanasia.
-
Biocon, Quark Get DCGI's Nod For Trials Of Eye Disease Drug
Biopharmaceutical firm Biocon on Thursday said the Drug Controller General of India (DCGI) has given nod to it and partner Quark Pharmaceuticals to proceed with clinical trials on human subjects for a new drug candidate, 'QPI-1007' aimed for ocular neuroprotection.
-
Aurobindo Pharma Gets US Regulator's Nod for Gastro Reflux Drug
Drug firm Aurobindo Pharma has received final approval from US Food and Drug Administration (FDA) to manufacture and market Esomeprazole Magnesium delayed release capsules, used in treatment of gastro-esophageal reflux disease, in the American market.
-
Lupin Launches Generic Aricept Tablets in US Market
Drug major Lupin has launched Donepezil Hydrochloride tablets, used in treating Alzheimer's disease, in the US market after having received the US health regulator USFDA's nod for the product earlier.
-
Aurobindo Pharma Gets Final US FDA Nod For Dementia Drug
Drug firm Aurobindo Pharma has received final approval from US FDA to manufacture and market Rivastigmine Tartrate Capsules USP, used for the treatment of dementia disease, in the American market.
-
Aurobindo Gets US Regulator's Nod to Market Heart Disease Drug
Aurobindo Pharma has received approval of the US Food and Drug Administration (FDA) to market injection Eptifibatide, used in the treatment of acute coronary syndrome, in the American market.
-
Aurobindo Gets US Regulator's Nod for Multi Disease Treatment Injection
Drug firm Aurobindo Pharma on Wednesday said it has received final approval of the US health regulator to manufacture and market its dexamethasone sodium phosphate injection, used to treat various conditions such as severe allergic reactions, arthritis and blood diseases.
-
Jubilant Life Gets US Regulator's Nod for Generic Dementia Tablets
Drug firm Jubilant Life Sciences has received final approval from the US Food and Drug Administration (FDA) for generic Memantine Hydrochloride tablets, used for treatment of dementia in patients with Alzheimer's disease.
-
Aurobindo Pharma Gets FDA Nod for 2 Generic Drugs
Aurobindo Pharma on Monday announced receipt of final approval from the US health regulator to manufacture and market its generic versions of Parkinson's disease treatment drug Entacapone tablets and antibiotics Azithromycin in the American market.
-
Strides Arcolab Gets USFDA Nod for Generic Skin Disease Cream
The Bangalore-based company has received approval from the US Food and Drug Administration (USFDA) for Imiquimod cream, Strides Arcolab Ltd said in a statement.
